Neues vom AstraZeneca Impfstoff und dessen möglicher Zulassung in der EU:
https://www.ema.europa.eu/en/news/em...ne-astrazeneca
Hieraus auszugsweise:
Zitat:
EMA has received an application for conditional marketing authorisation (CMA) for a COVID-19 vaccine developed by AstraZeneca and Oxford University. The assessment of the vaccine, known as COVID-19 Vaccine AstraZeneca, will proceed under an accelerated timeline. An opinion on the marketing authorisation could be issued by 29 January during the meeting of EMA’s scientific committee for human medicines (CHMP)(...)
|